CN Patent

CN108601733B — 卤倍他索泡沫组合物及其使用方法

Assigned to Therapeutics Inc · Expires 2021-11-09 · 5y expired

What this patent protects

本发明提供了用于治疗各种皮肤疾病的组合物和方法。该组合物被配制成可发泡组合物并且包括皮质类固醇卤倍他索。

USPTO Abstract

本发明提供了用于治疗各种皮肤疾病的组合物和方法。该组合物被配制成可发泡组合物并且包括皮质类固醇卤倍他索。

Drugs covered by this patent

halobetasol-propionate (HALOBETASOL PROPIONATE)

Patent Metadata

Patent number: CN108601733B
Jurisdiction: CN
Classification: —
Expires: 2021-11-09
Drug substance claim: No
Drug product claim: No
Assignee: Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.